Neuralink's 'Blindsight' for restoring sight is engineered and awaiting regulatory approval

Neuralink's Blindsight Product Revealed

Elon Musk has provided an update on Neuralink's second product, named 'Blindsight'. Musk stated that the technology is engineered and awaiting regulatory approval. This product is intended to enable individuals who are completely blind or have never seen to perceive visual information.

How Blindsight Functions

Unlike many current brain-computer interfaces (BCIs) that focus on brain-to-machine control, Blindsight aims to create an artificial visual pathway. It will use a camera to capture visual images, convert these signals, and then transmit them to the brain in a format it can interpret via the BCI.

Neuralink's Progress and First Product

Founded in 2016, Neuralink initiated human trials in 2024. Its first implantee initially controlled a mouse cursor with thoughts. The company's first product, 'Telepathy,' was announced by Musk, enabling high-speed communication with computers or humans through thought alone.

Broader BCI Landscape

While Neuralink is a prominent BCI company, other entities are also developing similar technologies. Meta is working on a non-invasive magnetoencephalography scanner for thought-to-keypress conversion, and China's NeuroXess plans human trials this year. The BCI sector is recognized as strategically important, with countries like China investing in its development.